Instruction
Stomatology is an academic journal in the field of oral medicine, mainly publishing the latest achievements and trends in both basic and clinical researches, aiming at providing up-to-date information for clinicians, professors, scientific researchers and students, and promoting the academic exchanges for the development of stomatology. Columns include Basic Research, Clinical Research, Investigation, Preventive Oral Medicine, Case Analysis, Review and Summary. Manuscripts from stomatological professionals are warmly welcome. The following requirements should be met.
Section 1 Submission Method
1. The journal implements online submission, review, revision, and proofreading. The website is www.stomatology.cn. Authors are requested to sign up and login to the online system. Registration information must be accurate. After submission, our journal will notify authors of the status of manuscript processing. Authors can also check the processing status through the online system. Word format should be adopted for manuscript (please refer to Template of Research Articles at "Download"). Paper manuscripts are not accepted since the online submission system was launched.
2. A recommendation letter from the first author's institute should be stamped with the official seal and submitted to the editorial office. A review fee of RMB 100 yuan per article will be charged when submitting online. According to national laws and regulations on copyright, the Copyright Transfer Agreement (template to be found at “Download”) should be signed by the first author or the corresponding author and posted to the editorial office along with the recommendation letter.
3. Once the publishing is confirmed, an APC shall be payable (RMB 600~800 yuan/page). After publication, a remuneration will be paid and two copies of the current journal will be posted to authors. Unless otherwise specified, both the remuneration and the sample journal will be posted to the first author.
4. All documents from the editorial office will be posted by express at the expense of the other party (authors).
5. If there are any honors awarded to the submitted manuscript, please notify the journal, which will reward authors based on the certificate of the award level.
Section 2 Writing Requirement
1. Basic Requirement: The manuscripts should be scientific, advanced and practical with explicit arguments. The materials and data should be authentic and reliable. The writing should be clear and coherent. The wordcount should be above 3500 Chinese Characters.
2. Funding: Should the manuscripts be funded at the national, ministerial, or provincial level, it should be footnoted on the title page. Those manuscripts will be given the first consideration for publication. Articles with prospective and creative significance will also be given priority for publishing.
3. Title: The title of each article should be concise and reflective of the content. Chinese title should have no more than 20 characters, usually with no English synonyms. English title should be consistent with the Chinese title with no more than 10 full words.
4. Authors: The author names should be arranged in order below title. The institutes (specifying department) and postal code of authors, and a brief introduction of the correspondent author (name, gender, professional title, academic degrees, date of birth, telephone number, fax number and E-mail address included) should be footnoted on the title page. The authors should be those who participate in the work described in the article and be responsible for the content.
5. Abstract: Abstract should have Chinese and English versions with 3 ~ 5 key words attached to them. The key words preferably should be selected form MeSH. If necessary, conventional words can be adopted and arranged in one line posteriorly. The abstract should include objectives, methods, results and conclusions written in the third person perspective. Chinese abstract should be about 300 characters. The English title, author names (Chinese Pinyin), institutes, the English abstract and key words should be consistent with the Chinese version. The names of all authors should be listed.
6. Headings: The headings in the main body text should be successively numbered in Arabic numerals in grading, such as 1, 1.1, 1.1.1.
7. Medical Terms: Medical terms should be selected from Medical Terminology published by the National Natural Sciences Terms Examination and Revision Committee and the English-Chinese Medical Vocabulary published by People's Health Press. Drug names should be from the latest edition of Pharmacopeia of the People's Republic of China.
8. Figures, Tables and Numerals: Figures and tables should be attached to the article and be numbered according to the order. Line charts should be clear, smooth, and logical. Photographs should be with good clarity and contrast ratio. Pathological photographs should display typical pathological changes and chromatic methods and amplification factors should be given. The annotations of figures or tables should be precise. The figures or tables should adopt three-line style with precise data and consistent decimal digits (usually two digits). The figures or tables should have Chinese and English titles. Statistical marks are written according to the prescriptions in GB33581393 Statistical Terms. Numbers are written according to GB/T5835-1995 Prescriptions of Numbers in Publications. Measurement units are written according to the Legal Measurement Units of the People's Republic of China published in 1984 and GB3100310293 Measurements and Units.
9. Abbreviations: Article title should not include abbreviations. Should an abbreviation first appear in the abstract and body, the full form in Chinese should be given and the full form in English and its abbreviation should be marked in brackets.
10. References: References should be written according to GB/T7714-1987 Writing Prescriptions of Posterior References. The Arabic numbers in brackets are arranged in order according to the sequences in the article. The proportion of references within 5 years should not be less than 2/3. The total number of references should be no less than 35 for review articles and no less than 20 for other articles.
Section 3 Peer Review and Editing
1. Review Policy: The journal follows a single-blind review process. After submission, the editorial office will firstly conduct a preliminary review of the manuscript. The editorial office will reject the manuscripts which are insufficient in originality, having serious scientific or technical mistakes, lacking valuable information, or not in the scope of the journal. The manuscripts which have passed the preliminary review will be sent to two or more reviewers. If the manuscript is accepted, the author may be requested to make revision according to the review feedback. It is recommended to mark the modifications in red characters so that editors can easily identify the change of text. The revised manuscript should be uploaded back to the submission system. If necessary, a statement should be provided against the comments from reviewers or editors. The editor-in-chief shall make the final decision for publishing. Authors should carefully proofread the final edition of the article.
2. Timing: If a notice of acceptance or revision is not posted in the online system within 6 months after submission, it is the case that the manuscript is still under review and processing. Authors should contact the editorial office before re-submitting the manuscript to another journal. If the revised manuscript is not returned more than two months beyond the time limit, it shall be deemed as withdrawal.
3. Editing Policy: All authors shall be responsible for their own writing. In accordance with relevant provisions of the Copyright Law, the journal can make textual amendments and deletions to the manuscript. However, if the amendment involves a change of meaning, the editorial office will contact the authors for confirmation. Authors should keep a copy of manuscript by themselves for the editorial office will not return any submitted file.
4. Submission by Editors: The editorial staff / editors / editorial board members should not be involved in publishing decisions on papers which they have written themselves or have been written by their family members or colleagues. Any such submission should be strictly subject to the journal’s usual editorial process. Peer review should be handled independently from the relevant author/editor and their research groups.
5. Correction and Retraction: After publishing, if there appears to be an unintended scientific mistake in the article which would not lead to significant impacts on the results and conclusion, the editorial office will publish corrections in the journal as soon as possible, and detailing the changes made to the original article. If severe scientific errors are found in published articles, or the article is suspected of academic misconduct, such as plagiarism and data falsification, the editorial office will issue a statement to inform readers of the risks, initiate an investigation and announce the final result, or even retract article with a retraction statement if necessary.
Section 4 Publishing Ethics
1. Plagiarism: This journal only accepts original articles that have not been submitted to other journals nor have been published, and the manuscripts submitted shall not contain any plagiarized content. All manuscripts would be tested by CNKI detection system and Wanfang detection system. Should any plagiarism be verified, the editorial office will immediately reject the manuscript all submission from all signed authors ever since. Any content overlapping with existing published works must have all necessary permissions and must be marked clearly in the manuscript.
2. Multiple Submission: Multiple submission or redundant publishing is strictly prohibited (including submission of the same content in different languages). Should multiple submission be verified, the editorial office will immediately reject the manuscript and all submission from corresponding authors ever since. Moreover, we will send a notice to other relevant journals in this field and to the author’s institutes, in case of which further penalty may be incurred.
3. Authorship: Those who are named as authors should directly participate in the research work, writing the manuscript or has an important guiding role (such as a graduate tutor). Other contributors of the paper (e.g., laboratory assistant) may be listed in acknowledgement. “Gift author” is strictly prohibited. If there is any non-Chinese citizen among authors, a letter of consent for publishing should be obtained. At least one author should be responsible for each main conclusion in the article. For a collective piece of work, there should be a person responsible for the whole paper. The authors should specify their contribution in the Authors Contribution Form and submit it along with the manuscript.
4. Medical Ethics: The ethical issue and informed consent of the study must comply with common principles of medical ethics. When research participants are humans, the author should explain whether its procedure comply with the ethical standards formulated by relevant committee (institutional, regional or national) responsible for human trials. The approval document of the committee should be submitted (the approval number should be included in the article). Consent letter from research participants or their relatives must be obtained, but not submitted to the editorial office. When reporting animal experiments, the study should comply with guidelines published by relevant committee on animal rights, and the approval document should be submitted.
5. Trial Registration: Clinical trials must include the Universal Trial Number (UTN) obtained from one of the Primary Registries in the WHO Registry Network. If applicable, the authors should specify the registering institution and the UTN within the article. The articles reporting randomized controlled trials shall comply with the standard of the CONSORT statement (http://www.consort-statement.org/home).
6. Conflict of Interest: All authors must disclose all potential conflicts of interest, i.e., when the financing/personal status/affiliation of the authors (or the authors' organization/employer) may affect the authors' decision, work or manuscript. When a product is mentioned, the author should also disclose whether there is a conflict of interest against competitive products. The authors should also fill and sign the Statement of Competing Interests and submit it along with the manuscript.
Section 5 Copyright and Archive
1. Open Access:Stomatology flipped to an open access journal in 2022. All articles ever since are immediately and permanently available for readers to read and download free of charge. Permitted third party reuse of the articles published by the journal is defined by the following user license: Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 (CC BY-NC-ND 4.0). This license allows reusers to copy and redistribute the material in any medium or format. The licensor cannot revoke these freedoms as long as the license terms below are followed: reusers must give appropriate credit, provide a link to the license, and indicate if changes were made. Reusers may do so in any reasonable manner, but not in any way that suggests the licensor endorses the use. Reusers may not use the material for commercial purposes. If reusers remix, transform, or build upon the material, they may not distribute the modified material. The authors have right to spread or make use of the article under the CC BY-NC-ND 4.0 License. The full details of the license are available at
https://creativecommons.org/licenses/by-nc-nd/4.0/
2. Copyright Transfer: Authors shall sign the Copyright Transfer Agreement, and agree to transfer the copyright of the article to the Editorial Office of Stomatology worldwide, including but not limited to the right of compilation; translation; reproduction for print/electronic/digital edition; information network dissemination; distribution.
3. Archive: All journal articles since 2022 can be downloaded from this website free of charge. These articles are open access with user’s rights defined by CC By-NC-ND 4.0 License. Articles published before 2022 are not open access. However, for articles published from 2013 to 2021, abstracts both in Chinese and English are accessible on this website; for articles published from 1983 to 2012, the Chinese abstracts are accessible. In order to ensure data security, soft copies and hard copies of the articles, supplements and other information have also been backed up in the editorial office.
Contact Information
Phone: 025-69593202
Email: kouqiangyixue@vip.163.com
Website: www.stomatology.cn
Address: Editorial Office of Oral medicine, No. 136, Hanzhong Road, Nanjing, Jiangsu Province.
Postal code: 210029.